Cause of death, by non-communicable diseases, ages 0-4, female in Oman
Oman: Cause of death, by non-communicable diseases, ages 0-4, female was 44.1% in 2021. ▬ Flat
Cause of death, by non-communicable diseases, ages 0-4, female in Oman, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in Oman stood at 44.1%.
The figure is down 1.5% on the previous year and up 0.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Oman peaked at 44.7% in 2020 and was at its lowest, 42.9%, in 2000.
That places Oman 25th out of 185 countries with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 0-4, female in Oman, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 42.9% | — |
| 2010 | 43.9% | +2.2% |
| 2015 | 43.1% | -1.7% |
| 2019 | 44.6% | +3.3% |
| 2020 | 44.7% | +0.4% |
| 2021 | 44.1% | -1.5% |
Oman compared with similar countries
- Oman's 44.1% is above the median for high income countries, which is 42.8%, 1.0× the median. (58 countries reporting)
- Oman's 44.1% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 35.2%, 1.3× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.9% | 42.9% | 42.9% | 1 |
| 2010s | 43.9% | 43.1% | 44.6% | 3 |
| 2020s | 44.4% | 44.1% | 44.7% | 2 |
Countries ranked near Oman
More health data for Oman
- Un projection of annual infant deaths, annual growth rate -0.8969 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3507 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 429.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 221 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.89 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0388 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Oman?
- Cause of death, by non-communicable diseases, ages 0-4, female in Oman was 44.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Oman?
- The highest recorded value was 44.7% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Oman?
- The lowest recorded value was 42.9% in 2000.
- How does Oman rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Oman ranks 25th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Oman?
- Over the last ten years it is up 0.5%. The long-run trend across the full record is flat.
- Where does this Oman data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.